Author

Yi Feng

Chinese Academy of Forestry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Arens TagaiD· 1 shared Bin LiaoiD· 1 shared Chunge ZhongiD· 1 shared Dake XuiD· 1 shared Danni ZhangiD· 1 shared Fei TengiD· 1 shared Fengxu YuiD· 1 shared Fengyun PeiiD· 1 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Arens TagaORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Deletion of Zyxin Reduces Endothelial Inflammation and Mitigates Atherosclerosis

Haozhong Huang, Yingzi Wang, Zhenyu Gao, Yi Feng, Tan Yang, Zihao Liu, Lei Li, Huimin Weng, Yi‐Quan Tang, Linlu Liu, Yuhao Li, Zhixin Li, Yucheng Xie, Bin Liao, Fengxu Yu, Yongmei Nie

This study shows that deleting zyxin in endothelial cells reduces inflammation and atherosclerosis by affecting the zyxin-14-3-3β-YAP signaling pathway.

bioRxiv · Oct 21, 2024 · PreprintCell Biology

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer

Chunge Zhong, Wenjie Jiang, Yingjia Yao, Zexu Li, You Li, Shengnan Wang, Xiaofeng Wang, Wenjuan Zhu, Siqi Wu, Jing Wang, Shuangshuang Fan, Shixin Ma, Yeshu Liu, Han Zhang, Wenchang Zhao, , Fei Teng

This study identifies convergent therapeutic targets for chemoresistance in cancer using CRISPR screens across multiple drug conditions and cancer models.

Nature Communications · Jun 29, 2024Peer-reviewedCancer Biology

Multi-omics analysis reveals the regulatory mechanism of flavonol biosynthesis during the formation of petal color in Camellia nitidissima

Yi Feng, Jiyuan Li, Xian Chu, Hengfu Yin, Zhengqi Fan, Suhang Yu, Minyan Wang, Xinlei Li, Weixin Liu

This study identifies the regulatory mechanism of flavonol biosynthesis during golden petal formation in Camellia nitidissima by integrating transcriptome, proteome, and metabolome data.

bioRxiv · Jan 3, 2023 · PreprintMolecular Biology

Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.

Qian Li, Yi Feng, Yingchao Xue, Xiping Zhan, Yi Fu, Gege Gui, Weiqiang Zhou, Jean‐Philippe Richard, Arens Taga, Pan P. Li, Xiaobo Mao, Nicholas John Maragakis, Mingyao Ying

This paper shows edaravone protects mRNA-induced motor neurons from neurotoxicity by activating the GDNF/RET signaling pathway and can replace neurotrophic factors for neuron survival.

Molecular Neurodegeneration · Jan 10, 2022Peer-reviewedNeuroscience

Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis

Kai Doberstein, Rebecca Spivak, Yi Feng, Sarah Stuckelberger, Gordon B Mills, Kyle M Devins, Lauren E Schwartz, Marcin P Iwanicki, Mina Fogel, Peter Altevogt, Ronny Drapkin

This study shows that L1CAM is essential for transformed fallopian tube secretory cells to detach, survive, and colonize the ovary in high-grade serous ovarian carcinoma.

bioRxiv · Mar 2, 2018 · PreprintCancer Biology